acute lymphoblastic leukemia
GPTKB entity
Properties (47)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
leukemia
|
| gptkbp:advertising |
gptkb:Leukemia_&_Lymphoma_Society
gptkb:National_Cancer_Institute gptkb:World_Health_Organization |
| gptkbp:aftermath |
more common in males
most common in children |
| gptkbp:age |
children
young adults |
| gptkbp:barrelLength |
lower in adults
higher in children |
| gptkbp:causedBy |
abnormal white blood cells
|
| gptkbp:clinicalTrials |
immunotherapy
targeted therapy new therapies |
| gptkbp:diseaseResistance |
varies by age
bone marrow biopsy varies by subtype |
| gptkbp:geneticDiversity |
gptkb:Philadelphia_chromosome
ETV6-RUNX1 fusion MLL_rearrangements |
| https://www.w3.org/2000/01/rdf-schema#label |
acute lymphoblastic leukemia
|
| gptkbp:impact |
growth factors
supportive care radiation therapy chemotherapy several months to years blood transfusions stem cell transplant antibiotics for infections |
| gptkbp:research |
ongoing studies
genetic profiling improved treatment protocols |
| gptkbp:riskManagement |
genetic disorders
exposure to radiation previous cancer treatment |
| gptkbp:runnerUp |
regular blood tests
monitoring for relapse |
| gptkbp:subclass |
B-cell ALL
T-cell ALL |
| gptkbp:symptoms |
fatigue
weight loss fever night sweats swollen lymph nodes pale skin easy bruising frequent infections |